Is Genenta Science SPA halal to invest in?

According to Musaffa's Shariah screening methodology, Genenta Science SPA (GNTA) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Genenta Science SPA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genenta Science SPA using these criteria to determine its compliance status.

Can Muslims buy shares of Genenta Science SPA?

Muslim investors may consider investing in Genenta Science SPA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Genenta Science SPA classified as NOT HALAL?

Musaffa determines the Shariah status of Genenta Science SPA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Genenta Science SPA updated?

The Shariah compliance status of Genenta Science SPA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Genenta Science SPA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Genenta Science SPA?

You can check the latest Shariah compliance status of Genenta Science SPA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GNTA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 27, 2025

Report Source: 2025 2nd Quarter Report

Genenta Science SPA. Stock Analysis GNTA

United States Health Care Nano Cap Report: Q2, 2025

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 9 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.

Key Statistics of Genenta Science SPA (GNTA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.59$0.68

Today's Open

$0.68

Volume

28.72K

P/E Ratio (TTM)

52 Week Range

$0.55$10.00

Market Cap

16.22M

Avg. Volume

50.27K

Dividend Yield

Financial Metrics & Statements of Genenta Science SPA (GNTA)

FAQ's for Genenta Science SPA (GNTA)

According to Musaffa’s Shariah screening methodology, Genenta Science SPA (GNTA) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.